SRSF2 and leukemia: Further research found that the SRSF2P95H mutation in leukemia inhibits SRSF2 recognition of m5C, affecting mRNA alternative splicing mediated by SRSF2, and leukemia patients with impaired SRSF2-m5C binding have poor prognosis (43).